These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Laparoscopic radical nephrectomy with hilar lymph node dissection in patients with advanced renal cell carcinoma. Simmons MN; Kaouk J; Gill IS; Fergany A Urology; 2007 Jul; 70(1):43-6. PubMed ID: 17656205 [TBL] [Abstract][Full Text] [Related]
5. European temporal trends in the use of lymph node dissection in patients with renal cancer. Capitanio U; Stewart GD; Larcher A; Ouzaid I; Akdogan B; Roscigno M; Marszalek M; Dell'Oglio P; Salagierski M; Volpe A; Mir MC; Kriegmair M; Terrone C; Brookman-May SD; Montorsi F; Klatte T; Eur J Surg Oncol; 2017 Nov; 43(11):2184-2192. PubMed ID: 28801061 [TBL] [Abstract][Full Text] [Related]
6. The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT Marchioni M; Bandini M; Pompe RS; Martel T; Tian Z; Shariat SF; Kapoor A; Cindolo L; Briganti A; Schips L; Capitanio U; Karakiewicz PI BJU Int; 2018 Mar; 121(3):383-392. PubMed ID: 28940649 [TBL] [Abstract][Full Text] [Related]
7. Extent of lymphadenectomy does not improve the survival of patients with renal cell carcinoma and nodal metastases: biases associated with the handling of missing data. Sun M; Trinh QD; Bianchi M; Hansen J; Abdollah F; Tian Z; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI BJU Int; 2014 Jan; 113(1):36-42. PubMed ID: 23490031 [TBL] [Abstract][Full Text] [Related]
8. Radical Nephrectomy With or Without Lymph Node Dissection for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-based Analysis. Gershman B; Thompson RH; Moreira DM; Boorjian SA; Tollefson MK; Lohse CM; Costello BA; Cheville JC; Leibovich BC Eur Urol; 2017 Apr; 71(4):560-567. PubMed ID: 27671144 [TBL] [Abstract][Full Text] [Related]
9. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma. Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492 [TBL] [Abstract][Full Text] [Related]
10. Lymph node dissection at the time of radical nephrectomy for high-risk clear cell renal cell carcinoma: indications and recommendations for surgical templates. Crispen PL; Breau RH; Allmer C; Lohse CM; Cheville JC; Leibovich BC; Blute ML Eur Urol; 2011 Jan; 59(1):18-23. PubMed ID: 20933322 [TBL] [Abstract][Full Text] [Related]
11. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach. Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334 [TBL] [Abstract][Full Text] [Related]
12. [Renal cell carcinoma]. Shimazui T; Kawai K; Akaza H Gan To Kagaku Ryoho; 2004 Nov; 31(12):2073-5. PubMed ID: 15570943 [TBL] [Abstract][Full Text] [Related]
13. Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection. Pantuck AJ; Zisman A; Dorey F; Chao DH; Han KR; Said J; Gitlitz BJ; Figlin RA; Belldegrun AS J Urol; 2003 Jun; 169(6):2076-83. PubMed ID: 12771723 [TBL] [Abstract][Full Text] [Related]
14. Valuation of lymph node dissection in localized high-risk renal cell cancer using X-tile software. Zhuang W; Chen J; Li Y; Liu W Int Urol Nephrol; 2020 Feb; 52(2):253-262. PubMed ID: 31612422 [TBL] [Abstract][Full Text] [Related]
15. Impact of lymphadenectomy and nodal burden in renal cell carcinoma: retrospective analysis of the National Surveillance, Epidemiology, and End Results database. Joslyn SA; Sirintrapun SJ; Konety BR Urology; 2005 Apr; 65(4):675-80. PubMed ID: 15833507 [TBL] [Abstract][Full Text] [Related]
16. Staging lymphadenectomy in renal cell carcinoma must be extended: a sensitivity curve analysis. Capitanio U; Suardi N; Matloob R; Abdollah F; Castiglione F; Briganti A; Carenzi C; Roscigno M; Montorsi F; Bertini R BJU Int; 2013 Mar; 111(3):412-8. PubMed ID: 22703190 [TBL] [Abstract][Full Text] [Related]
17. The role of lymph node dissection in renal cell carcinoma. Delacroix SE; Chapin BF; Wood CG Urol Clin North Am; 2011 Nov; 38(4):419-28, vi. PubMed ID: 22045173 [TBL] [Abstract][Full Text] [Related]
18. Overall survival in patients with metastatic renal cell carcinoma and clinical N1 disease undergoing cytoreductive nephrectomy and lymph node dissection. Faiena I; Salmasi A; Lenis AT; Donin NM; Johnson DC; Bachour K; Drakaki A; Belldegrun AS; Pantuck AJ; Chamie K Urol Oncol; 2018 Feb; 36(2):79.e19-79.e26. PubMed ID: 29103965 [TBL] [Abstract][Full Text] [Related]
19. Influence of lymph node dissection in patients undergoing radical nephrectomy for non-metastatic renal cell carcinoma: a systematic review and meta-analysis. Luo X; Li JX; Liu YT; Zou G; Yao WX; Qing GQ; Yang RL; Ye XY; Facchini G; Rossetti S Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6079-6090. PubMed ID: 31364109 [TBL] [Abstract][Full Text] [Related]
20. A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma. Blute ML; Leibovich BC; Cheville JC; Lohse CM; Zincke H J Urol; 2004 Aug; 172(2):465-9. PubMed ID: 15247704 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]